With a market cap of $218.8 billion, Abbott Laboratories (ABT) is a global healthcare leader with a diversified portfolio ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter ...

The stock's fall snapped a two-day winning streak.

Wondering if Abbott Laboratories is undervalued, fairly priced, or perhaps even a hidden bargain? You are not alone, as many investors are taking a closer look at this healthcare giant. The stock is ...

Abbott Laboratories (NYSE:ABT) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...

Abbott (ABT) closed at $134.59 in the latest trading session, marking a +1.2% move from the prior day. This move outpaced the S&P 500's daily gain of 0.01%. At the same time, the Dow added 0.51%, and ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Shares of Abbott Laboratories ABT shed 1.41% to $127.63 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.63% to 6,629.07 and ...